Raj Anshu, Shuklan Priyanka, Madan Preety, Chauhan Khushboo, Phogat Jatin, Rani Sudesh
Department of Zoology, Maharshi Dayanand University, Rohtak 124001, Haryana, India.
Department of Biochemistry, Maharshi Dayanand University, Rohtak 124001, Haryana, India.
ACS Omega. 2023 Jul 31;8(32):29270-29280. doi: 10.1021/acsomega.3c02626. eCollection 2023 Aug 15.
In this study, albino Wistar rats that have developed diabetes as a result of the drug streptozotocin (STZ) were treated with camel milk and insulin. For this, 36 rats were divided into six different ( = 6) groups: control, control + camel milk, diabetic control, insulin, camel milk, and combined camel milk + insulin. A 50 mg/kg intraperitoneal injection of STZ was used to induce diabetes. Rats with blood glucose levels exceeding 250 mg/dL after the induction of diabetes were taken into consideration for the study. The diabetic rats were treated with camel milk (50 mL/rat/day), insulin (6 units kg b·wt/day), or their combination daily for 30 days. Throughout the course of the study, the rats' glucose levels and body weight were checked. In the diabetic control rats, a reduction in body weight and hyperglycemic condition was seen. Improvements in glycemic levels and weight gain were seen in the camel milk, insulin, and combined treatment groups compared to the diabetic control group; however, the combined treated group did not show the same degree of improvement as the alone treated group. Hematological changes in the diabetic control group included reductions in lymphocytes, platelets, total leukocyte count (TLC), and red blood cell (RBC) indices (mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), packed cell volume (PCV), and mean cell hemoglobin concentration (MCHC)). Each group that got insulin and camel milk separately and combined showed improvement in these changes. The liver, kidney, and pancreas in the diabetic control group had worsened morphological alterations. These histopathological alternations were significantly improved in the treatment groups. Hence, this study demonstrates the antidiabetic effects of camel milk in comparison to insulin. These findings highlight the potential of camel milk as an alternative therapy for diabetes, although further research is warranted to fully understand its mechanisms of action and long-term effects.
在本研究中,使用链脲佐菌素(STZ)诱导患糖尿病的白化Wistar大鼠接受骆驼奶和胰岛素治疗。为此,将36只大鼠分为六个不同(n = 6)的组:对照组、对照组 + 骆驼奶组、糖尿病对照组、胰岛素组、骆驼奶组以及骆驼奶 + 胰岛素联合组。采用50 mg/kg腹腔注射STZ诱导糖尿病。诱导糖尿病后血糖水平超过250 mg/dL的大鼠纳入本研究。糖尿病大鼠每天接受骆驼奶(50 mL/只/天)、胰岛素(6单位/kg体重/天)或二者联合治疗,持续30天。在整个研究过程中,检测大鼠的血糖水平和体重。糖尿病对照组大鼠出现体重减轻和高血糖状况。与糖尿病对照组相比,骆驼奶组、胰岛素组及联合治疗组的血糖水平有所改善且体重增加;然而,联合治疗组的改善程度不如单独治疗组。糖尿病对照组的血液学变化包括淋巴细胞、血小板、白细胞总数(TLC)及红细胞(RBC)指标(平均红细胞体积(MCV)、平均红细胞血红蛋白含量(MCH)、血细胞比容(PCV)和平均红细胞血红蛋白浓度(MCHC))降低。单独及联合给予胰岛素和骆驼奶的各组这些变化均有改善。糖尿病对照组的肝脏、肾脏和胰腺出现形态学改变恶化。治疗组的这些组织病理学改变明显改善。因此,本研究证明了骆驼奶与胰岛素相比具有抗糖尿病作用。这些发现凸显了骆驼奶作为糖尿病替代疗法的潜力,不过仍需进一步研究以全面了解其作用机制和长期效果。